ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,040,446 | -14.3% | 155,059 | +3.4% | 0.14% | +94.4% |
| Q2 2022 | $1,214,000 | -41.7% | 150,000 | 0.0% | 0.07% | +4.4% |
| Q1 2022 | $2,082,000 | -76.1% | 150,000 | -41.4% | 0.07% | -74.3% |
| Q3 2021 | $8,699,000 | -29.7% | 255,916 | -15.5% | 0.26% | -31.2% |
| Q2 2021 | $12,382,000 | +19.8% | 303,032 | +18.1% | 0.38% | +30.5% |
| Q1 2021 | $10,335,000 | -41.7% | 256,694 | -14.4% | 0.30% | -54.3% |
| Q4 2020 | $17,733,000 | +63.2% | 299,898 | +34.2% | 0.64% | +15.2% |
| Q3 2020 | $10,864,000 | +236.7% | 223,400 | +234.9% | 0.56% | +80.6% |
| Q2 2020 | $3,227,000 | -40.4% | 66,700 | -65.8% | 0.31% | -51.8% |
| Q1 2020 | $5,417,000 | +235.2% | 195,000 | +261.0% | 0.64% | +352.8% |
| Q4 2019 | $1,616,000 | -4.4% | 54,010 | +54.3% | 0.14% | -44.7% |
| Q2 2019 | $1,691,000 | – | 35,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |